Short-term exposure to dimethyl fumarate (DMF) inhibits LPS-induced IκBζ expression in macrophages

Yong Zhang1, Jingshu Tang1, Yujun Zhou1

  • 1State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Frontiers in Pharmacology
|February 23, 2023
PubMed

Insights

Dimethyl fumarate (DMF) rapidly depletes glutathione, activating the Nrf2 pathway and inhibiting inflammatory gene expression. This demonstrates DMF

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • The precise pharmacological mechanisms of dimethyl fumarate (DMF) for psoriasis and multiple sclerosis (MS) remain unclear.
  • While monomethyl fumarate (MMF) is the presumed active metabolite, DMF's short in-vivo half-life raises questions about its direct therapeutic role.

Purpose of the Study:

  • To investigate the direct anti-inflammatory effects of short-term dimethyl fumarate (DMF) exposure.
  • To compare the anti-inflammatory efficacy of DMF and MMF in vivo.

Main Methods:

  • Utilized lipopolysaccharide (LPS)-stimulated RAW264.7 cells and whole blood assays to model inflammation.
  • Assessed inflammatory markers (nitrite, cytokines, IκBζ) using Griess assay, qPCR, ELISA, and Western blot.
  • Investigated the roles of glutathione (GSH), Nrf2-ARE pathway, STAT3, and Nfkbiz using biochemical and molecular assays.

Main Results:

  • Short-term DMF exposure significantly reduced inflammatory responses and suppressed IκBζ expression in vitro.
  • Oral DMF administration, but not MMF, inhibited IκBζ transcription in murine peripheral blood.
  • DMF depleted intracellular GSH, activated the Nrf2-ARE pathway, and inhibited STAT3 binding to the IκBζ promoter.

Conclusions:

  • Dimethyl fumarate (DMF) exhibits rapid, direct anti-inflammatory effects in macrophages.
  • These findings support a direct therapeutic role for DMF beyond its metabolite MMF.